Sigilon Therapeutics Inc. (SGTX) Social Stream
Sigilon Therapeutics Inc (SGTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Sigilon Therapeutics Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 35 weeks, SGTX's average price target has gone down $42.95.
Over the past 49 weeks, SGTX's average upside potential has been 282.55%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SGTX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Sigilon Therapeutics Inc's variance in analysts' estimates is less than -395.27% of all US stocks.
- Sigilon Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 483.5% of all US stocks.
- The average analyst price target of SGTX is higher than 116.84% of all US stocks.
- SGTX has a greater number of analysts covering the stock than 166.15% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Sigilon Therapeutics Inc are CEMI, ARDX and TRDA.
Is SGTX a Buy, Hold or Sell? See the POWR Ratings now!